Grifols joins Barcelona Health Hub to boost its innovation projects

Barcelona Health Hub is proud to announce that Grifols has recently become a part of its digital health ecosystem. Through this partnership, Grifols aims to further immerse itself in the world of digital health and build on its understanding of advancements in the field.

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people around the world. A leader in essential plasma-derived medicines and transfusion medicine, the company develops, produces and provides innovative healthcare services and solutions in more than 110 countries. Patient needs and Grifols’ ever-growing knowledge of many chronic, rare and prevalent conditions, at times life-threatening, drive the company’s innovation in both plasma and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases.

"Grifols is delighted to join Barcelona Health Hub’s digital health ecosystem, an opportunity for us to accelerate our efforts to incorporate the most advanced digital platforms and technologies into our work helping patients lead better lives," said Albert Grifols Coma-Cros, Grifols' Chief Scientific Innovation Officer.

Barcelona Health Hub is confident that Grifols, with its expertise and experience in the healthcare industry, will be a significant asset to the BHH digital health ecosystem. With a long history of developing innovative healthcare solutions, Grifols is well-positioned to bring valuable insights and leading innovation to the ecosystem. Additionally, Grifols' commitment to improving the health and well-being of people around the world aligns perfectly with the mission of Barcelona Health Hub, making it a natural fit and a great addition for the BHH digital health ecosystem.